Venlafaxine Hydrochloride
NDC 65862-528, Venlafaxine Hydrochloride, capsule, extended release, from Aurobindo Pharma Limited.
- Product NDC
- 65862-528
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA200834
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65862-528 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- VENLAFAXINE HYDROCHLORIDE75 mg/1
Pharmacologic classes
Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65862-528-01 | 65862052801 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-528-01) |
| 65862-528-10 | 65862052810 | 10 BLISTER PACK in 1 CARTON (65862-528-10) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK |
| 65862-528-30 | 65862052830 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-528-30) |
| 65862-528-35 | 65862052835 | 3500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-528-35) |
| 65862-528-47 | 65862052847 | 15 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-528-47) |
| 65862-528-90 | 65862052890 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-528-90) |
| 65862-528-99 | 65862052899 | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-528-99) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/85d3ce8b-8966-45d9-bdaf-f6f0475096e1NADAC price for package 65862052801
GET /v1/drugs/nadac/65862052801NADAC price for package 65862052830
GET /v1/drugs/nadac/65862052830NADAC price for package 65862052890
GET /v1/drugs/nadac/65862052890NADAC price for package 65862052899
GET /v1/drugs/nadac/65862052899
Use it
Look up 65862-528 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65862-528 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65862-528. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.